Amid weak global cues, the Indian markets concluded Monday’s session on a lower note, as the Sensex and the Nifty50 both witnessed heavy selling pressure each down over 2 per cent, all sectoral indices ended lower, while the Nifty Bank lead the decline. 

COMMERCIAL BREAK
SCROLL TO CONTINUE READING

Ajit Mishra, VP - Research, Religare Broking Ltd said, “The markets reacted to the news of a sharp jump in the COVID cases globally which may result in a lockdown. Though the situation is under control domestically, any impact on the global economic recovery would dent our prospects too.”

See Zee Business Live TV Streaming Below:

 “Reiterating cautious view on markets, Mishra added, “Investors, on the other hand, can start accumulating quality stocks selectively from a long term investment perspective, as the Nifty50 has the next major support at 16,300 levels.”

Stay tuned to Zeebiz.com to find out what could impact your trade today. We have collated a list of top 10 news points which could impact markets, companies, or economy:  

Global Markets:

Wall Street indices lower due to concerns surrounding Omicron. Dow Jones corrected 1.23%, Nasdaq Composite dipped 1.24% and S&P 500 ended 1.14% lower on Monday.

Asian Markets:

A day after starting negative, major Asian markets were trading in the green on Tuesday. Japanese Nikkei 225 was trading with 1.54% gain, Hang Seng Index was up 0.56% and Shnaghai Composite Index .23%.

SGX Nifty:

SGX Nifty Futures opened 163 points higher to 6821 around 7.15 am, hinting at positive opening for the Indian markets.

Oil prices post weekly loss on Omicron uncertainty

Oil prices slumped more than 5% on Monday as surging cases of the Omicron coronavirus variant in Europe and the United States stoked investor worries that new restrictions to combat its spread could dent fuel demand.

Brent crude futures were down $3.98, or 5.4%, at $69.54 a barrel by 11:01 a.m. EST (1601 GMT), while U.S. West Texas Intermediate (WTI) crude futures fell $4.51, or 6.4%, to $66.35 a barrel. Both benchmarks were at their lowest levels since early December.

"This is a knee-jerk reaction to the proliferation of the virus and the fear that lockdowns can rapidly spread," said Andrew Lipow of Lipow Oil Associates in Houston.

The Netherlands went into on Sunday and the possibility of more COVID-19 restrictions being imposed ahead of the Christmas and New Year holidays loomed over several European countries.

MapMyIndia IPO: Shares to make a strong debut on Tuesday

C.E Info Systems Limited-backed MapmyIndia is all set to market debut on Tuesday, December 21, 2021. The majority of analysts, including Zee Business Managing Editor Anil Singhvi, expect the company to make bumper listing around 70-75 per cent returns, as estimated. 

The initial public offer of MapMyIndia was launched between December 9-13, 2021, and the issue was subscribed by 154 times, led by strong demand from non-institutional investors. The NII quota was filled almost 425 times, followed by qualified institutional buyers over 196 times on final day. 

The market expert Aayush Agrawal, who is a senior analyst at Swastika Investmart Ltd in his listing estimates said that it was expected MapMyIndia’s stock market debut would give over 100 per cent return on a listing day, however, the expectations have tapered down amid sharp correction in the market where the grey market premium is indicating a listing gain of around 70-75 per cent.

Rupee firms up 16 paise to 75.90/US

The rupee notched up gains for a third straight session on Monday, rising further by 16 paise to settle at 75.90 (provisional) against the US dollar as easing crude oil prices revived an otherwise lacklustre sentiment.

Massive sell-offs in domestic equities, sustained foreign fund outflows and concerns around Omicron variant of coronavirus were a host of factors restricting rupee gains, forex traders said.

Starting off on a tepid note, the rupee weakened to a low of 76.16 before staging a recovery. It hit the day's high at 75.83 against the dollar, before closing at 75.90, clocking a gain of 16 paise.

Last week, the local unit recorded its fourth weekly decline amid growing concerns over the Omicron variant of coronavirus. Experts, however, are of the view that as major events of the year are almost done, forex markets may stay calm in the coming week.

EPFO adds 12.73 lakh subscribers in Oct

Retirement fund body EPFO has added 12.73 lakh net subscribers in October, registering an increase of 10.22 per cent compared to the same month last year, according to the latest payroll data.

"The provisional payroll data of EPFO released on 20th December 2021 highlights that EPFO has added 12.73 lakh net subscribers during the month of October 2021," a labour ministry statement said.

According to the statement, year-on-year comparison shows an increase of around 10.22 per cent in net payroll additions in October, 2021 as compared to 11.55 lakh net subscribers added during October 2020.

Of the total 12.73 lakh net subscribers added, 7.57 lakh new members have been enrolled under EPF & MP Act, 1952 for the first time.

Ixigo, Keventer Agro get Sebi's go-ahead to float IPOs

Le Travenues Technology Ltd, which operates travel platform Ixigo, has received markets regulator Sebi's go-ahead to raise Rs 1,600 crore through an initial share-sale.

Apart from this, cardiac stent maker Sahajanand Medical Technologies and food and beverage major Keventer Agro have received regulatory approval from Sebi to float their initial public offerings (IPOs).

These three companies, which filed their preliminary IPO papers with Sebi between August and September, obtained observation letter from the regulator during December 16-17, an update with the markets watchdog showed on Monday.

Supriya Lifescience IPO subscribed 71.51 times on last day

The initial public offer of Supriya Lifescience Limited was subscribed 71.51 times on the last day of share sale on Monday. The initial share sale received bids for 1,03,89,57,138 shares against 1,45,28,299 shares on offer, according to NSE data.

The category for non-institutional investors was subscribed 161.22 times while that for Retail Individual Investors (RIIs) by 56.01 times and the Qualified Institutional Buyers' (QIBs) quota by 31.83 times.

The initial public offer (IPO) of Supriya Lifescience was fully subscribed within a few hours of opening for subscription on Thursday on the back of a strong response from retail investors.

FII & DII Data:

Foreign portfolio investors (FPIs) remained net sellers for Rs 3565.36 crore in the Indian markets while Domestic Institutional Investors (DIIs) were net buyers to the tune of Rs 2764.02 crore, provisional data showed on the NSE.

Stocks under F&O ban on NSE  

Two stocks: Indiabulls Housing and Escorts are placed under the F&O ban on Monday. Securities in the ban period under the F&O segment include companies in which the security has crossed 95 percent of the market-wide position limit.

(With inputs from PTI, Reuters and other agencies)

(Disclaimer: The views/suggestions/advices expressed here in this article is solely by investment experts. Zee Business suggests its readers to consult with their investment advisers before making any financial decision.)